Search research articles
Contact Us
Filters
Showing results (91-100 of 239) with videos related to
Page
of 24
Sort By:
Plos One
|
July 5, 2012
The anti-tumor effect of A3 adenosine receptors is potentiated by pulsed electromagnetic fields in cultured neural cancer cells
Fabrizio Vincenzi, Martina Targa, Carmen Corciulo, et al.
Pharmaceutics
|
October 28, 2023
Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases Therapy
Mercedes Fernandez, Manuela Nigro, Alessia Travagli, et al.
Current Medicinal Chemistry
|
June 25, 2005
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine ligands, new tools to characterize A3 adenosine receptors in human tumor cell lines
Pier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Romeo Romagnoli, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 17, 2009
Adenosine modulates HIF-1{alpha}, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cells
Stefania Gessi, Eleonora Fogli, Valeria Sacchetto, et al.
Neurobiology of Disease
|
August 19, 2014
Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington's disease
Antonella Ferrante, Alberto Martire, Rita Pepponi, et al.
American Journal of Respiratory and Critical Care Medicine
|
September 28, 2010
A₃ receptors are overexpressed in pleura from patients with mesothelioma and reduce cell growth via Akt/nuclear factor-κB pathway
Katia Varani, Stefania Maniero, Fabrizio Vincenzi, et al.
Pharmacology & Therapeutics
|
October 11, 2003
A glance at adenosine receptors: novel target for antitumor therapy
Stefania Merighi, Prisco Mirandola, Katia Varani, et al.
Neoplasia (New York, N.Y.)
|
October 2, 2009
A(2B) and A(3) adenosine receptors modulate vascular endothelial growth factor and interleukin-8 expression in human melanoma cells treated with etoposide and doxorubicin
Stefania Merighi, Carolina Simioni, Stefania Gessi, et al.
European Journal of Medicinal Chemistry
|
March 12, 2018
The aminopyridine-3,5-dicarbonitrile core for the design of new non-nucleoside-like agonists of the human adenosine A<sub>2B</sub> receptor
Marco Betti, Daniela Catarzi, Flavia Varano, et al.
The International Journal of Neuropsychopharmacology
|
July 27, 2006
ST 1535: a preferential A2A adenosine receptor antagonist
Maria Antonietta Stasi, Franco Borsini, Katia Varani, et al.
Page
of 24
Search research articles
Search
Showing results (91-100 of 239) with videos related to
Sort By:
Page
of 24
Plos One
|
July 5, 2012
The anti-tumor effect of A3 adenosine receptors is potentiated by pulsed electromagnetic fields in cultured neural cancer cells
Fabrizio Vincenzi, Martina Targa, Carmen Corciulo, et al.
Pharmaceutics
|
October 28, 2023
Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases Therapy
Mercedes Fernandez, Manuela Nigro, Alessia Travagli, et al.
Current Medicinal Chemistry
|
June 25, 2005
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine ligands, new tools to characterize A3 adenosine receptors in human tumor cell lines
Pier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Romeo Romagnoli, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 17, 2009
Adenosine modulates HIF-1{alpha}, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cells
Stefania Gessi, Eleonora Fogli, Valeria Sacchetto, et al.
Neurobiology of Disease
|
August 19, 2014
Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington's disease
Antonella Ferrante, Alberto Martire, Rita Pepponi, et al.
American Journal of Respiratory and Critical Care Medicine
|
September 28, 2010
A₃ receptors are overexpressed in pleura from patients with mesothelioma and reduce cell growth via Akt/nuclear factor-κB pathway
Katia Varani, Stefania Maniero, Fabrizio Vincenzi, et al.
Pharmacology & Therapeutics
|
October 11, 2003
A glance at adenosine receptors: novel target for antitumor therapy
Stefania Merighi, Prisco Mirandola, Katia Varani, et al.
Neoplasia (New York, N.Y.)
|
October 2, 2009
A(2B) and A(3) adenosine receptors modulate vascular endothelial growth factor and interleukin-8 expression in human melanoma cells treated with etoposide and doxorubicin
Stefania Merighi, Carolina Simioni, Stefania Gessi, et al.
European Journal of Medicinal Chemistry
|
March 12, 2018
The aminopyridine-3,5-dicarbonitrile core for the design of new non-nucleoside-like agonists of the human adenosine A<sub>2B</sub> receptor
Marco Betti, Daniela Catarzi, Flavia Varano, et al.
The International Journal of Neuropsychopharmacology
|
July 27, 2006
ST 1535: a preferential A2A adenosine receptor antagonist
Maria Antonietta Stasi, Franco Borsini, Katia Varani, et al.
Page
of 24